Market Overview

RedHill Biopharma Announces $6M Private Placement From OrbiMed Israel Partners Limited Partnership

RedHill Biopharma (Nasdaq: RDHL) today announced that it has entered into a definitive agreement with leading healthcare investor OrbiMed Israel Partners Limited Partnership, an affiliate of OrbiMed Advisors LLC, for the sale of RedHill's American Depository Shares and warrants in a private placement transactionor a total sum of $6.0 million.

See full press release

Posted-In: News Guidance Financing Offerings Contracts Management Global

 

Most Popular

Related Articles (RDHL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free